Human Immunodeficiency Virus (HIV)–Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy
Jenny L. Anderson(The Royal Melbourne Hospital), Sharon R. Lewin(Peter Doherty Institute), Rémi Fromentin(Centre Hospitalier de l’Université de Montréal), Jeffrey M. Milush(University of California, San Francisco), Matthew J. Gartner(RMIT University), Rebecca Hoh(University of California, San Francisco), Wendy Hartogensis(University of California, San Francisco), Frederick Hecht(University of California, San Francisco), Gabriela Khoury(Burnet Institute), C. Lorrie Epling(University of California, San Francisco), Matthew C. Pitman(The Royal Melbourne Hospital), Paul Cameron(The Royal Melbourne Hospital), Peter Bacchetti(University of California, San Francisco), Steven G. Deeks(University of California, San Francisco), Nicolas Chomont(Vaccine & Gene Therapy Institute of Florida), Carolin Tumpach(Peter Doherty Institute), Michael Roche(The University of Melbourne), Elizabeth Sinclair(San Francisco General Hospital), Ajantha Solomon(The Royal Melbourne Hospital), Ma Somsouk(University of California, San Francisco)
Cited by 52
Related Papers
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
|AIDS|2000|1k
Systemic Effects of Inflammation on Health during Chronic HIV Infection
|Immunity|2013|835
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
|Blood|2004|787
Defective proviruses rapidly accumulate during acute HIV-1 infection
|Nature Medicine|2016|774